Changes to the website
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 5039

Next 25
Website Changes
07/09/2020 Ziopharm Oncology Doses First DIPG Patient in Phase 1/2 Trial of Controlled IL-12 for the Treatment of Pediatric Brain Tumors
07/08/2020 Musella Foundation awards another brain tumor research grants!
07/07/2020 Survival, Costs, and Health Care Resource Use by Line of Therapy in US Medicare Patients With Newly Diagnosed Glioblastoma: A Retrospective Observational Study
07/03/2020 Everolimus improves the efficacy of dasatinib in PDGFRa-driven glioma
07/03/2020 Valganciclovir as Add-on to Standard Therapy in Glioblastoma Patients
07/03/2020 Is polio the answer to curing brain tumors?
07/01/2020 Early Imaging Marker of Progressing Glioblastoma: A Window of Opportunity
06/30/2020 Musella Foundation awards two more brain tumor research grants!
06/29/2020 First annual Dragon Derby!
06/29/2020 A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study
06/29/2020 We need your supprt for the Promising Pathway Act
06/28/2020 David Zagzag, MD, Ph.D. Recognized as a Professional of the Year for 2020 by Strathmore`s Who`s Who Worldwide
06/27/2020 ERC Belgium Submits Marketing Authorization Application to European Medicines Agency (EMA) for Glioblastoma Immunotherapy, SITOIGANAP
06/25/2020 A Systematic Review of Tumor Treating Fields Therapy for High-Grade Gliomas
06/24/2020 Musella Foundation Copay Program now closed to new patients
06/24/2020 New class of precision medicine strips cancer of its DNA defenses
06/24/2020 DelMar Pharmaceuticals Presents Positive Interim Data on VAL-083 Demonstrating Favorable Outcomes in Both Newly- Diagnosed and Recurrent GBM at the AACR Virtual Annual Meeting II
06/22/2020 Exploiting Cancer’s Tactics to Make Cancer a Manageable Chronic Disease
06/21/2020 Brain Tumor Webinars continue tonight! Sunday 6/21/2020 7pm Eastern Time
06/18/2020 Gallagher, Colleagues Introduce Bipartisan Promising Pathways Act
06/15/2020 Karyopharm Announces Dosing of First Patient in a Phase 1/2 Study of Selinexor in Combination with Standard of Care Therapy for Patients with Newly Diagnosed or Recurrent Glioblastoma
06/15/2020 Global Post-Marketing Safety Surveillance of Tumor Treating Fields (TTFields) in Patients With High-Grade Glioma in Clinical Practice
06/15/2020 The Musella Foundation Awards 2 Brain Tumor Research Grants
06/15/2020 Cancer Vaccine Plus Adoptive T-cell Therapy Placed on Fast Track
06/13/2020 Brain Tumor Webinar Series continues tonight! 6/14/2020



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740